The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazole.

MLA

Ayan-Oshodi, Mosun A., et al. “The Effects on Metabolic Clearance When Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole.” Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 40, no. 10, Oct. 2012, pp. 1945–52. EBSCOhost, https://doi.org/10.1124/dmd.112.046060.

APA

Ayan-Oshodi, M. A., Willis, B. A., Annes, W. F., Lowe, S. L., Friedrich, S., de la Peña, A., Zhang, W., Brown, T., Wise, S. D., & Hall, S. D. (2012). The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazole. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 40(10), 1945–1952. https://doi.org/10.1124/dmd.112.046060

Chicago

Ayan-Oshodi, Mosun A, Brian A Willis, William F Annes, Stephen L Lowe, Stuart Friedrich, Amparo de la Peña, Wei Zhang, Thomas Brown, Stephen D Wise, and Stephen D Hall. 2012. “The Effects on Metabolic Clearance When Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole.” Drug Metabolism and Disposition: The Biological Fate of Chemicals 40 (10): 1945–52. doi:10.1124/dmd.112.046060.